K. Kikuchi et al., GROWTH-REGULATION IN SCLERODERMA FIBROBLASTS - INCREASED RESPONSE TO TRANSFORMING GROWTH-FACTOR-BETA-1, Journal of investigative dermatology, 105(1), 1995, pp. 128-132
We investigated the responses of normal and scleroderma fibroblasts to
various growth factors, especially transforming growth factor-beta 1
(TGF-beta 1). The effects of various growth factors on [H-3]thymidine
incorporation in normal and scleroderma fibroblasts were examined. [I-
125]-labeled platelet-derived growth factor (PDGF)-BB binding in scler
oderma and normal fibroblasts was examined both in the presence and ab
sence of TGF-beta 1 (1 ng/ml), Cytoplasmic protein was isolated and an
alyzed by Western blotting, Total RNA from fibroblasts was also isolat
ed and analyzed by reverse transcriptase-polymerase chain reaction (RT
-PCR) using specific primer sets. Mitogenic responses to TGF-beta 1 (0
.33-1 ng/ml) in seven scleroderma fibroblast strains were significantl
y greater than those in normal controls, [I-125]-PDGF-BB binding to sc
leroderma fibroblasts was increased after TGF-beta 1 stimulation, The
increased response to TGF-beta 1 was shown to be mediated through PDGF
-like protein induction; TGF-beta 1-treated scleroderma fibroblasts pr
oduced greater amounts of 36-kD PDGF-like protein, which was reported
previously as connective tissue growth factor (CTGF), than did TGF-bet
a 1-treated normal fibroblasts. TGF-beta 1 treatment also upregulated
PDGF-alpha receptor expression in scleroderma fibroblasts but not in n
ormal dermal fibroblasts. mRNA expression of CTGF and PDGF-alpha recep
tor was correlated with the above protein expression. These observatio
ns suggest that the increased growth response to TGF-beta 1 in sclerod
erma fibroblasts is mediated through the induction of CTGF and PDGF-al
pha receptor.